Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity.

Diabetes Metab Syndr Obes · 2014 · PMC3944999 · PMID 24611021

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

76 There was a trend for beloranib to be associated with a reduction in the percentage of subjects with metabolic syndrome that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.